Drugs / [F-18]RDG-K5
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01968226 | Nov 2013 → Jun 2016 | carotid stenosis | The Cleveland Clinic | Terminated | No outcome recorded |
| Phase 2 | NCT01602471 | May 2012 → Mar 2013 | carotid stenosis | Siemens Molecular Imaging | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | [F-18]RDG-K5 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01602471 ↗ |
| Modality | Diagnostic / imaging agent | “radiolabeled PET tracer” NCT01968226 ↗ |
| Route | Intravenous | “after intravenous administration of this radiolabeled tracer using PET imaging.” NCT01968226 ↗ |